Survey and Research Archives | Page 3 of 46 | Be Korea-savvy

Archive by category Survey and Research

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

SINGAPORE, Sept. 19, 2023 (Korea Bizwire) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best CRO for Cell & Gene Therapy 2023 at the Asia Pacific Cell & Gene Therapy Excellence Awards. Novotech’s Vice President, Clinical Services Dr. Yooni Kim accepted the award at [...]

[Correction] “Averting the SaaS Data Apocalypse” by Simon Taylor: A Journey Through the SaaS Data Landscape

[Correction] “Averting the SaaS Data Apocalypse” by Simon Taylor: A Journey Through the SaaS Data Landscape

New Book is a Comprehensive Exploration of the Rising Threat to Digital Data and the Race to Protect It Boston, Massachusetts, Sept. 18, 2023 (Korea Bizwire) – Please use the below updated release: HYCU, Inc., the fastest growing data protection as a service company is taking a major first step as the digital world is [...]

Purdue Researcher Awarded $1.3 Million for Malaria Drug Trials in Southeast Asia and Africa

Purdue Researcher Awarded $1.3 Million for Malaria Drug Trials in Southeast Asia and Africa

Philip Low looks to validate previous trial results and test whether the number of days of an anti-malaria drug therapy can be reduced WEST LAFAYETTE, Ind., Sept. 15, 2023 (Korea Bizwire) – A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries. Open Philanthropy has awarded [...]

Critical Crossroads: AEC Industry’s Contribution to Global Carbon Emissions Is A Shocking Statistic

Critical Crossroads: AEC Industry’s Contribution to Global Carbon Emissions Is A Shocking Statistic

With the Architecture, Engineering, and Construction (AEC) industry contributing more than 37% of global carbon emissions,a new report by RIB Software reveals the urgent need for action to combat rising greenhouse gas emissions. This not only a challenge for the AEC industry, but an imperative for mankind.  According to a panel of climate experts and [...]

Rome’s Luiss University Continues to Grow in the International Ranking of the Financial Times

Rome’s Luiss University Continues to Grow in the International Ranking of the Financial Times

Rome, Italy, Sept. 14, 2023 (Korea Bizwire) – Rome’s Luiss University welcomed the freshmen of the new academic year with the most positive result ever coming from the recently published ranking of the Financial Times. Luiss University continues its ascent, climbing over twenty positions compared to 2022 to achieve 30th place in the world for the master’s degree in “Management” (it [...]

The 2023 CBI Index – The Ultimate Cross-Jurisdictional Investment Tool Launched

The 2023 CBI Index – The Ultimate Cross-Jurisdictional Investment Tool Launched

Showcasing the best countries to invest in this year London, Sept. 14, 2023 (Korea Bizwire) – Today, the seventh edition of the CBI Index launched, providing captivating insights into the world’s top investment migration programmes in 2023. From inception, the CBI Index, published in partnership with the Financial Times’ Private Wealth Magazine has been comprehensively ranking operational Citizenship by [...]

Nasdaq Study Shows Legacy Technology and Regulation Preventing Financial Institutions From Capturing Growth Opportunities

Nasdaq Study Shows Legacy Technology and Regulation Preventing Financial Institutions From Capturing Growth Opportunities

78% of FMI investment budgets dominated by maintaining and upgrading legacy technology, with more than a third planning a major system overhaul in the next five years Industry-wide need to upgrade legacy technology, whilst responding to wave of regulation, risks compromising resilience or missing out on growth opportunities NEW YORK, Sept. 14, 2023 (Korea Bizwire) [...]

Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine

Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine

Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA) ALBANY, N.Y., Sept. 13, 2023 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced that its partner, Replicate Bioscience, has received IND clearance from the FDA and has dosed the first participant with [...]

Io Therapeutics, Inc., Announces Publication of Data on a Novel Compound Promoting Anti-Cancer Immune Responses

Io Therapeutics, Inc., Announces Publication of Data on a Novel Compound Promoting Anti-Cancer Immune Responses

SPRING, Texas, Sept. 12, 2023 (Korea Bizwire) – Io Therapeutics, Inc., announced today the publication in Scientific Reports – Nature Publishing Group, of results from studies done with the company’s novel anti-cancer compound IRX4647, an agonist of the retinoic acid nuclear receptor gamma, discovered in the company’s oncology drug program. The paper, titled “A novel retinoic acid [...]

Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News

Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News

BOSTON, Sept. 11, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in China: Unlocking the Potential of Advanced Therapies. Novotech is collaborating with Endpoints News to jointly host this webinar. The webinar will examine how China’s focus on cutting-edge innovations and [...]